Please provide your email address to receive an email when new articles are posted on . Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second ...

Alcon will acquire LENSAR for $356 million, including its laser treatment system and software technology. A contingent value right of up to $2.75 per share is linked to achieving 614,000 procedures by ...

Alcon's acquisition of Aurion Biotech enhances its cell therapy capabilities for eye diseases, with Aurion operating independently under Alcon's support. Aurion's AURN001, an allogeneic cell therapy ...

The companies will come together to advance robotic laser technology in cataract surgery; improving precision, reducing patient comfort, and providing faster recovery time. Read on to find out ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and LENSAR, Inc. (NASDAQ: LNSR), a global medical technology company focused on advanced laser ...

Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology will be expanded globally, improving the efficiency of ...

When you reach the northern side of the temple, you should be able to spot the red butterfly on a nearby tree. A blue butterfly can be found directly west of the Temple of Osaka. Head in this ...

Blue chip stocks are from well-established companies with reliable profit records. They offer stable dividends and are favored for long-term investment security. Diversifying portfolios with blue ...

Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon's cataract equipment and technology portfolio Next generation technology will be expanded globally, improving the efficiency of ...

Investopedia / Zoe Hansen A traditional and perhaps outdated term, "blue collar" is a type of job that is done outside the office, often with manual labor or trade skills. The term blue collar is ...